Dong-E-E-Jiao Co.,Ltd.

000423

CNE0000006Y9

Pharmaceuticals

End-of-day quote Shenzhen S.E. Other stock markets 2025-04-24			5-day change	1st Jan Change
63.10 ^CNY	+2.25%		-0.32%	+0.61%

Mar. 17	China Resources Pharmaceutical Posts FY Revenue RMB5.92 Bln For Dong-E-E-Jiao	RE
Mar. 17	Dong-E-E-Jiao Co.,Ltd. Reports Earnings Results for the Full Year Ended December 31, 2024	CI

UBS Adjusts Dong-E E-Jiao’s Price Target to 40.75 Yuan From 39.30 Yuan, Keeps at Neutral

August 23, 2022 at 04:13 am EDT

This article is reserved for members

Unlock the article: REGISTER NOW!

100% Free Registration

Already a customer? Log In

Latest news about Dong-E-E-Jiao Co.,Ltd.

China Resources Pharmaceutical Posts FY Revenue RMB5.92 Bln For Dong-E-E-Jiao	Mar. 17	RE
Dong-E-E-Jiao Co.,Ltd. Reports Earnings Results for the Full Year Ended December 31, 2024	Mar. 17	CI
Dong-E-E-Jiao to See Boost in 2024 Profit	Jan. 20	MT
Dong-E-E-Jiao Co.,Ltd. Provides Earnings Guidance for the Year Ended 31 December 2024	Jan. 17	CI
Macquarie Starts Dong-E-E-Jiao at Outperform with 70 Yuan Price Target	Nov. 18	MT
Dong-E-E-Jiao Co.,Ltd. Announces Directorate Appointments	Nov. 11	CI
Dong-E-E-Jiao's Q3 Profit Jumps 64%, Operating Income Climbs 25%	24-10-31	MT
Dong-E-E-Jiao Co.,Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2024	24-10-30	CI
Dong-E-E-Jiao Chairman Steps Down	24-10-23	MT
Chinese Shares Rise on Stimulus Hopes; Shengtak New Material, Dong-E-E-Jiao, Tech-Bank Food Close With Gains	24-10-10	MT
Dong-E-E-Jiao Expects Q3 Profit to Rise Up to 73%; Shares Climb 7%	24-10-10	MT
China Resources Pharmaceutical Group Limited Announces Resignation of Bai Xiaosong as Chief Executive Officer	24-08-29	CI
Dong-E-E-Jiao Co.,Ltd. Reports Earnings Results for the Half Year Ended June 30, 2024	24-08-16	CI
Dong-E-E-Jiao Co.,Ltd. Announces Board Appointments	24-08-08	CI
China Renaissance Starts Dong-E-E-Jiao at Buy With 83.78 Yuan Price Target	24-07-29	MT
Dong-E-E-Jiao Forecasts Up to 43% Rise in H1 Profit	24-07-12	MT
Dong-E-E-Jiao Plans Sale of 46 Million Yuan Property	24-07-08	MT
Dong-E-E-Jiao Co.,Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024	24-04-25	CI
Dong-E-E-Jiao Forecasts Up to 55% Jump in Q1 Profit	24-04-12	MT
Dong-E-E-Jiao's Profit Jumps 47.6% in 2023	24-03-22	MT
Dong-E-E-Jiao Co.,Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023	24-03-21	CI
Dong-E-E-Jiao Co.,Ltd.'s Equity Buyback announced on January 2, 2024, has closed with 1,512,400 shares, representing 0.23% for CNY 75.87 million.	24-01-24	CI
Tranche Update on Dong-E-E-Jiao Co.,Ltd.'s Equity Buyback Plan announced on January 2, 2024.	24-01-24	CI
Dong-E-E-Jiao Co.,Ltd. announces an Equity Buyback for 1,660,000 shares, for CNY 124.2 million.	24-01-02	CI
Dong-E-E-Jiao Co.,Ltd. authorizes a Buyback Plan.	23-12-30	CI

Dong-E-E-Jiao Co., Ltd. specializes in the manufacturing and marketing of Chinese traditional medicines and health products. The products are primarily for deficiencies in the blood, immunodeficiency, indigestion, insomnia and fatigue.

Employees

4,095

Sector

Pharmaceuticals

Calendar

Aug. 20 - Q2 2025 Earnings Release (Projected)

More about the company